buyout
Risk Reduction
Medically underwritten annuity specialist Partnership wrote £84m in bulk annuity business in 2013 according to the company's annual results.
19 March 2014
•
Risk Reduction
Insurers and consultants have set up an industry-wide committee to develop a good practice guide for medically underwritten bulk annuity transactions.
14 March 2014
•
Risk Reduction
Blackrock chief executive officer (CEO) Larry Fink has said many schemes are not counting the cost of longevity which could have a detrimental impact on their liabilities.
06 March 2014
•
Risk Reduction
Engineering giant GKN has completed a £123m buy-in with Rothesay Life in its latest step towards a full scheme buyout.
06 March 2014
•
Risk Reduction
Jack Jones asks whether it is inevitable all bulk deals will be medically underwritten in future
06 March 2014
•
Defined Benefit
The trustees of the Dynochem UK Pension Scheme have concluded a £15m buyout of pensioner liabilities and 100 members with the Pension Insurance Corporation (PIC).
25 February 2014
•
Risk Reduction
Defined benefit (DB) schemes in the UK pay considerably more to offload liabilities to an insurer than schemes in other countries, according to research from Mercer.
25 February 2014
•
Defined Benefit
Trustees should explore reshaping benefit structures before entering into a buyout to avoid paying over the odds for inflation hedging, say consultants.
20 February 2014
•
Risk Reduction
Jack Jones examines whether there are benefits for early movers in the medically underwritten bulk annuity market
06 February 2014
•
Risk Reduction
Three investors have completed a deal to buy a two-third stake in Rothesay Life from parent company Goldman Sachs, after receiving regulatory approval.
20 December 2013
•
